共 130 条
[31]
Holliger S(2011)Botulinum toxin type A in patients with Parkinson’s disease and refractory overactive bladder J Urol 186 960-8
[32]
Schletterer K(2014)Onabotulinumtoxin A office treatment for neurogenic bladder incontinence in Parkinson’s disease Urology 83 22-42
[33]
Berger Y(2013)le Comité de neuro-urologie de l’Association française d’urologie. “Lower urinary tract dysfunctions in parkinsonian syndromes: a review by the Neuro-Urology Comittee of the French Association of Urology.” [Article in French] Prog Urol 23 296-7
[34]
Blaivas JG(2013)Transcutaneous tibial nerve stimulation in the overactive bladder syndrome in patients with Parkinson’s syndromes Prog Urol 23 936-83
[35]
DeLaRocha ER(1988)Post-prostatectomy continence in the parkinsonian patient: the significance of poor voluntary sphincter control J Urol 140 117-undefined
[36]
Salinas EM(2009)Benign prostatic obstruction and parkinson’s disease – should transurethral resection of the prostate be avoided? J Urol 181 2209-undefined
[37]
Ragab MM(2008)Augmentation Cystoplasty: what are the indications? Curr Urol Rep 9 452-undefined
[38]
Mohammed ES(2013)The impact of deep brain stimulation on the nonmotor symptoms of Parkinson’s disease J Neural Transm. 120 639-undefined
[39]
Siegl E(2012)Immediate effects of deep brain stimulation of the subthalamic nucleus on nonmotor symptoms in Parkinson’s disease Parkinsonism Relat Disord 18 994-undefined
[40]
Lassen B(2012)Bladder dysfunction in advanced Parkinson’s disease Neurourol Urodyn. 31 1279-undefined